In addition, like YAP/TAZ, FAK acts as a co-transcriptional activator in the cell nucleus through its contribution to the control of TFs on both the protein and gene expression levels (e.g., p53, see Section 2.4.2, FAK in Cancer, and c-jun). The gene discussed is PTK2; the disease is cancer.